Directorate Change
21 December 2020
On December 21, 2020, Dr. Kunwar Shailubhai resigned as a director of Rasna Therapeutics, Inc. (the “Company”) for personal reasons and on December 23, 2020, the Board of the Company appointed Gary S. Jacob as a director of the Company.
Willy Simon Appointed as Chairman of Rasna Therapeutics, Inc.
15 October 2020
NEW YORK—Oct. 15, 2020 (BUSINESS WIRE)--Rasna Therapeutics, Inc. (OTCQB: RASP), a development biotechnology company focused on the development of disease-modifying drugs for hematological malignancies, today announced that Willy Simon has been appointed as the Chairman of Rasna Therapeutics, replacing Alessandro...
Directorate Change
10 July 2019
Rasna today announces that Alex Martin has resigned as a director of Rasna Therapeutics, Inc. for personal reasons. Mr. Martin’s resignation is not a result of any disagreement with the Company, the Company’s management or the Board of Directors.
Rasna Therapeutics, Inc. Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-mutated Acute Myeloid Leukemia
03 January 2018
-
Treatment with Actinomycin D (Act D) as a single drug achieved complete remission in 4 out of 9 evaluable patients (44.4%).
-
Treatment with Act D at 15 µg/kg/day for 5 days every 28 days (which defines one cycle) was well tolerated...